Corporate Banner
Satellite Banner
Biomolecular Screening
Scientific Community
 
Become a Member | Sign in
Home>Events>This Event
  Events - June 2014


15th Annual Drug Discovery Leaders Summit

02 Jun 2014 - 03 Jun 2014 - Geneva, Switzerland



Bookmark and Share


Attend Europe’s leading networking and discussion platform for drug discovery professionals.  

Meet 250 senior-level delegates from global pharmaceutical organisations, leading biotechs and esteemed academic institutions.

Hear 60 expert speakers discuss the pressing challenges in medicinal chemistry, compound screening, target-based discovery and innovation access.

Discuss the viability of the latest discovery trends, including phenotypic screening, epigenetic drug discovery, stem cell technology and nanoengineering.

Tailor your congress experience – attend any sessions from the following six streams:

- R&D Models For The Future

- Screening & Assays: Enabling Technologies

- Target Based Discovery

- Supporting Innovation: Data & Information Management

- Discovery Chemistry: Latest Case Studies

- Drug Design: Novel Approaches

The Summit is co-located with the 6th Annual Drug Development Congress - an executive level event focusing on predictive science and translational medicine.

The Drug Discovery Summit is Europe’s leading networking and discussion platform for pharmaceutical professionals. Attending this long-established event gives delegates the opportunity to:

Hear from and meet with the people shaping the pharmaceutical landscape. Previous attendees include: Vice President New Frontier Science Europe, Takeda; Vice President and Venture Leader, Janssen R&D; Vice President & Global Head, Reagents & Assay Development, AstraZeneca.

Discuss the latest discovery innovations, including 3D cell based assays, advances in nanoengineering and iPSCs for compound screening.

Discover collaborative solutions to discovery challenges. This summit brings together a host of experts to compare methods for utilising new screening technology, validating novel drug targets, improving lead optimisation and making better use of discovery data.

Enjoy unparalleled networking opportunities. The two-day congress format combines dedicated networking breaks, pre-organised 1-2-1 meetings and our popular drinks reception. The exhibition hall and poster presentation spaces offer a relaxed and professional environment for discussion.

Tailor the congress experience.  The six stream agenda offers industry updates for those working in discovery technology, target-based discovery, discovery information, discovery chemistry, drug design, research strategy and open innovation.

Contact Danielle Dalby to download the agenda and for attendance information on d.dalby@oxfordgloabl.co.uk or call +44 (0)1865 248455



Further information
Scientific News
New Cancer Drug Target in Dual-Function Protein
Scientists at The Scripps Research Institute (TSRI) have identified a protein that launches cancer growth and appears to contribute to higher mortality in breast cancer patients.
Penn State, TB Alliance, and GSK Partner To Discover New Treatments For TB
A new collaboration between TB Alliance, GSK, and scientists in the Eberly College of Science seeks to find new small molecules that can be used to create antibiotics in the fight against tuberculosis (TB).
Molecular Map Provides Clues To Zinc-Related Diseases
Mapping the molecular structure where medicine goes to work is a crucial step toward drug discovery against deadly diseases.
Platelets are the Pathfinders for Leukocyte Extravasation During Inflammation
Findings from the study could help in the prevention and treatment of inflammatory pathologies.
Genetic Research Can Significantly Improve Drug Development
With drug development costs topping $1.2bn (£850 million) to get a single treatment to the point it can be sold and used in the clinic, could genetic analysis save hundreds of millions of dollars?
New Method Opens Door to Development of Many New Medicines
Findings from TSRI reveal human proteins are better drug targets than previously thought.
Diagnosing Systemic Infections Quickly, Reliably
Team develop rapid and specific diagnostic assay that could help physicians decide within an hour whether a patient has a systemic infection and should be hospitalized for aggressive intervention therapy.
What Makes a Good Scientist?
It’s the journey, not just the destination that counts as a scientist when conducting research.
Blood Test That Detects Early Alzheimer’s Disease
A research team, led by Dr. Robert Nagele from Rowan University School of Osteopathic Medicine and Durin Technologies, Inc., has announced the development of a blood test that leverages the body’s immune response system to detect an early stage of Alzheimer’s disease – referred to as the mild cognitive impairment (MCI) stage – with unparalleled accuracy.
A New Approach to Chemical Synthesis
Communesins, originally found in fungus, could hold potential as cancer drugs.
Scroll Up
Scroll Down
SELECTBIO

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,200+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,700+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!